Analysis of the North American Immune Tolerance Registry (NAITR) 1993-1997: current practice implications. ISTH Factor VIII/IX Subcommittee Members.
DiMichele
D M
DM
New York Hospital/Cornell University Medical College, New York, NY and Research Triangle Institute, Rockville, Md, USA.
Kroner
B L
BL
D000906:Antibodies / Q000627:therapeutic use; D016208:Databases, Factual; D005164:Factor IX / Q000008:administration & dosage / Q000276:immunology; D005169:Factor VIII / Q000008:administration & dosage / Q000276:immunology; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D009656:North America / Q000453:epidemiology; D012042:Registries; D013997:Time Factors; D016896:Treatment Outcome
D000906:Antibodies; D005169:Factor VIII; D005164:Factor IX